Trial Profile
Open-label Early Phase 2 Study With a Single Arm of Interferon Gamma-1b Treatment of Osteopetrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2023
Price :
$35
*
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Osteopetrosis
- Focus Adverse reactions
- 01 Jul 2019 Status changed from active, no longer recruiting to completed.
- 06 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.